Q1 earnings season for the advanced bioeconomy kicked off this week, with reporting from Green Plains, ADM, REG and BioAmber. That’s an ag giant, an ethanol monster, a biomass-based diesel dominator and a fast-upcoming renewable chemicals maker. Between the four, we have a good opportunity to check the sector’s health. Overall, markets were unhappy today, […]
In Ontario, Comet Biorefining has signed an off-take agreement with bio-succinic acid producer BioAmber for cellulosic dextrose from Comet’s upcoming first commercial plant in Sarnia, Ontario. The dextrose will be produced from agricultural residues using Comet’s innovative technology. The agreement also provides increasing shape to the development of an biobased industrial cluster in the Sarnia […]
In California and Canada this week, BioAmber, Pacific Ethanol and the former Solazyme reported their Q4 and year-end results, providing between them a fascinating look at the evolution in the fuels, renewable chemicals, specialty products and nutrition that make up the advanced bioeconomy. In advanced nutrition The most spectacular news of the week belonged to […]
From the company’s IPO Prospectus: “Our proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals. The development of our current organism was originally funded by the DOE in the late 1990s, was further developed and scaled up, and optimized at […]
The Digest Bioeconomy Index, an index of publicly traded advanced bioeconomy stocks, dropped 1.56 percent to 48.67 as advanced bio and ethanol retreated. For the day, BioAmber (BIOA) fell 6.28 percent to $3.73, while Aemetis (AMTX) lost 4.86 percent to $1.95. Among other equities, Solazyme (SZYM) tumbles 7.59 percent to $1.46. Overall, declines led advances […]
In the Netherlands, Reverdia and BioAmber have inked a non-assert agreement concerning Reverdia’s Biosuccinium technology. BioAmber Inc. and Reverdia are both involved in the production and commercialization of bio-based succinic acid using their own unique proprietary yeast-based technologies. Pursuant to the key provisions of this agreement, BioAmber will benefit from non-assertion covenants with respect to […]
Ultra-secret yeast tech also exceeding expectations in yield, productivity and quality, BioAmber reports. Baby Sarnia checks in at 60 million pounds, no ounces, doing fine. In Canada, BioAmber’s Sarnia joint venture with Mitsui & Co. Ltd. has begun shipping bio-succinic acid to customers and is operating its manufacturing process at commercial scale, meeting a significant company […]
From the company’s IPO Prospectus: “Our proprietary technology platform combines industrial biotechnology, an innovative purification process and chemical catalysis to convert renewable feedstocks into chemicals that are cost-competitive replacements for petroleum-derived chemicals. The development of our current organism was originally funded by the DOE in the late 1990s, was further developed and scaled up, and optimized […]
Unique synthetic leather fabric has 70% bio-content, based on BioAmber’s Bio-SA and DuPont Tate & Lyle Bio Products’ PDO In Canada, BioAmber announced that the Flokser Group has successfully developed an innovative artificial leather fabric using bio-based materials supplied by DuPont Tate & Lyle Bio Products and BioAmber. Flokser has launched this new synthetic leather fabric […]
Project of the Year, Deal of the Year, Partnership of the Year, Chemical of the Year, and Cap Raise of the Year — who are the big winners? Each year, the Digest recognizes projects, feedstocks, processing technology breakthroughs, novel or improved molecules, and bioeconomy pioneers in the Biofuels Digest Awards — selected by the Digest’s […]
